TRXC - TransEnterix soars as its Intelligent Surgical Unit wins European nod

TransEnterix (TRXC) received CE Mark approval for the Intelligent Surgical Unit that enables machine vision capabilities on the Senhance Surgical System.The approval will provide Senhance digital laparoscopic programs in Europe access to this new technology, ushering them to the forefront of surgical innovation utilizing augmented intelligence.This Intelligent Surgical Unit is compatible with both the global installed base of Senhance Surgical Systems and with third-party vision systems that are currently supported by Senhance.Shares +12% premarket.

For further details see:

TransEnterix soars as its Intelligent Surgical Unit wins European nod